1. Home
  2. SNY vs UL Comparison

SNY vs UL Comparison

Compare SNY & UL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • UL
  • Stock Information
  • Founded
  • SNY 1994
  • UL 1930
  • Country
  • SNY France
  • UL United Kingdom
  • Employees
  • SNY N/A
  • UL N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • UL Package Goods/Cosmetics
  • Sector
  • SNY Health Care
  • UL Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • UL Nasdaq
  • Market Cap
  • SNY 144.8B
  • UL 151.6B
  • IPO Year
  • SNY N/A
  • UL N/A
  • Fundamental
  • Price
  • SNY $55.82
  • UL $59.17
  • Analyst Decision
  • SNY Buy
  • UL Strong Buy
  • Analyst Count
  • SNY 2
  • UL 4
  • Target Price
  • SNY $62.50
  • UL $66.00
  • AVG Volume (30 Days)
  • SNY 3.0M
  • UL 2.5M
  • Earning Date
  • SNY 04-24-2025
  • UL 04-08-2025
  • Dividend Yield
  • SNY 3.94%
  • UL 3.17%
  • EPS Growth
  • SNY 2.94
  • UL N/A
  • EPS
  • SNY 4.60
  • UL 2.37
  • Revenue
  • SNY $45,849,466,833.00
  • UL $62,906,097,959.00
  • Revenue This Year
  • SNY $6.91
  • UL $5.65
  • Revenue Next Year
  • SNY $6.60
  • UL $3.05
  • P/E Ratio
  • SNY $23.82
  • UL $25.00
  • Revenue Growth
  • SNY 7.73
  • UL 1.94
  • 52 Week Low
  • SNY $45.22
  • UL $46.46
  • 52 Week High
  • SNY $60.12
  • UL $65.87
  • Technical
  • Relative Strength Index (RSI)
  • SNY 47.61
  • UL 57.12
  • Support Level
  • SNY $53.98
  • UL $57.67
  • Resistance Level
  • SNY $56.93
  • UL $59.29
  • Average True Range (ATR)
  • SNY 0.78
  • UL 0.56
  • MACD
  • SNY -0.56
  • UL -0.07
  • Stochastic Oscillator
  • SNY 31.19
  • UL 62.29

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About UL Unilever PLC

Unilever is a diversified personal-care (52% of 2022 sales by value), homecare (14%), and packaged food (34%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Axe and Dove skin products, and the TRESemmé haircare brand. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, Garancia, and The Vegetarian Butcher.

Share on Social Networks: